+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Assisted Reproductive Technology Market by Technique, Cycle Type, Treatment, End User, Product - Global Forecast to 2030- Product Image
Assisted Reproductive Technology Market by Technique, Cycle Type, Treatment, End User, Product - Global Forecast to 2030- Product Image
Sale

Assisted Reproductive Technology Market by Technique, Cycle Type, Treatment, End User, Product - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4904634
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Assisted Reproductive Technology Market grew from USD 29.52 billion in 2024 to USD 34.76 billion in 2025. It is expected to continue growing at a CAGR of 17.62%, reaching USD 78.18 billion by 2030.

Shaping the Future of Assisted Reproductive Technologies

Assisted reproductive technologies have evolved from experimental endeavors into sophisticated clinical solutions that underpin modern fertility care. As demographic shifts, delayed parenthood and rising prevalence of infertility converge, stakeholders across healthcare systems are intensifying their focus on advanced reproductive innovation. This surge in demand has catalyzed unprecedented investment in laboratory processes, precision genetics and end-to-end patient support frameworks. Against this dynamic backdrop, our report navigates the core developments shaping the assisted reproductive technology landscape, offering clarity on the forces driving transformation and the strategic imperatives for growth.

The interplay of technological breakthroughs, regulatory recalibrations and shifting patient expectations defines today’s market complexity. Innovations in gamete handling, embryo viability assessment and cryopreservation logistics are redefining success metrics and operational efficiency. Simultaneously, policy shifts-particularly tariff adjustments and cross-border care considerations-are prompting stakeholders to recalibrate supply chains and partnership models. As both clinical sophistication and geopolitical nuance intensify, this report establishes a foundational understanding of critical trends, preparing decision-makers to anticipate opportunities and mitigate risks in an increasingly competitive environment.

Emerging Dynamics in Assisted Reproductive Solutions

The assisted reproductive technology marketplace is experiencing a paradigm shift as precision medicine and digital integration coalesce. Genetic testing algorithms now inform embryo selection with greater accuracy, enhancing implantation outcomes while reducing cycle attrition. Concurrently, artificial intelligence-driven analytics are streamlining treatment planning and patient engagement, enabling clinics to optimize resource allocation and personalize care pathways. These technological inflections are complemented by an expanding portfolio of minimally invasive procedures that reduce patient discomfort and accelerate recovery, advancing the sector’s clinical benchmarks.

Beyond the laboratory, patient-centric service models are redefining the infertility journey. Telemedicine platforms facilitate remote consultation and real-time monitoring, ensuring continuity of care for patients navigating geographical constraints. In tandem, collaborative networks linking fertility clinics, ambulatory surgical centers and diagnostic laboratories foster seamless referral pathways and data interoperability. This convergence of clinical, technological and operational innovations marks a transformative phase, setting a new standard for integrated, outcomes-driven reproductive health solutions.

Navigating the 2025 U.S. Tariff Landscape

The overhaul of U.S. tariffs in 2025 has introduced a complex matrix of cost considerations for equipment, media, reagents and specialized accessories central to assisted reproduction workflows. Import duties on advanced microscopes, incubators and cryostorage systems have shifted procurement strategies, compelling providers to balance quality imperatives against heightened expenditure pressures. Clinics are responding by diversifying supplier relationships, exploring regional sourcing hubs and reevaluating inventory management to mitigate margin erosion.

At the same time, adjustments in import levies for consumables-ranging from pipettes to culture media-have triggered a recalibration of unit costs across treatment cycles. Stakeholders are leveraging economies of scale to negotiate volume-based agreements, while some manufacturers are restructuring their global distribution footprints to localize manufacturing and streamline cross-border logistics. This tariff-driven realignment is reshaping the cost architecture of assisted reproductive services, underscoring the importance of agile supply chain governance and strategic procurement partnerships in sustaining operational resilience.

Unveiling Core Market Segmentation

The assisted reproductive technology market can be dissected through multiple lenses, each revealing unique insights into adoption patterns and investment priorities. From the technique perspective, the spectrum encompasses gamete intrafallopian transfer, in vitro fertilization, intracytoplasmic sperm injection, intrauterine insemination and zygote intrafallopian transfer. Within the in vitro fertilization segment, nuanced differentiation emerges across fresh donor, fresh non-donor and frozen cycles, reflecting varied clinical protocols and patient affordability considerations. When examining cycle type, the emphasis on fresh donor, fresh non-donor and frozen approaches highlights divergent success probabilities, cost structures and patient preferences.

Treatment modalities further diversify the landscape through cryopreservation, embryo transfer, genetic testing and oocyte retrieval offerings. End users span ambulatory surgical centers, fertility clinics and hospitals, each facility type shaping volume throughput and procedural complexity. Product segmentation reveals distinct demand curves for consumables, equipment, media and reagents, as well as service-based solutions. Together, these segmentation frameworks converge to inform market penetration strategies, enabling stakeholders to tailor portfolio investments and target high-growth subcategories with precision.

Regional Perspectives Driving Market Growth

Regional dynamics play a pivotal role in shaping competitive positioning and growth trajectories within the assisted reproductive technology sector. In the Americas, robust clinical infrastructure, widespread insurance coverage and an emphasis on innovation drive high adoption rates of advanced procedures. North American centers of excellence continue to pioneer cutting-edge protocols, while Latin American markets exhibit rising demand fueled by expanding private healthcare networks.

Across Europe, Middle East & Africa, regulatory harmonization and public-private partnerships are bolstering access to fertility services, with several nations implementing supportive policies to address demographic challenges. The region’s blend of well-established research institutes and emerging provider networks fosters a collaborative ecosystem, accelerating technology transfer and clinical trial activity. In the Asia-Pacific, rapid urbanization, increasing disposable incomes and a focus on medical tourism underpin sustained market expansion. Governments are investing in healthcare infrastructure and workforce development to meet rising patient volumes, positioning the region as a key growth frontier for assisted reproductive care providers.

Profiling Leading Innovators in ART

Several industry leaders are at the forefront of innovation, shaping both technological advancement and strategic direction within assisted reproductive technology. A cohort of pioneering firms is leveraging proprietary platforms for embryo viability analytics, while others are expanding their global footprints through targeted partnerships and acquisitions. Collaborative ventures between diagnostic specialists and device manufacturers are producing end-to-end solutions designed to streamline laboratory workflows and enhance treatment outcomes.

At the same time, service-oriented enterprises are differentiating through comprehensive patient support offerings, integrating genetic counseling and digital care coordination into their value proposition. Equipment suppliers are prioritizing modular designs and automation features to reduce human error and optimize throughput. Across this competitive landscape, market incumbents are continuously refining their R&D pipelines, underscoring the sector’s commitment to iterative innovation and clinical excellence.

Strategic Imperatives for Industry Leaders

Industry leaders must prioritize supply chain agility, integrating regional sourcing strategies to buffer against tariff volatility and logistical disruptions. Investing in localized manufacturing capabilities can reduce lead times and mitigate currency exposure, while strategic alliances with logistics providers can secure preferential transit rates. Concurrently, embracing digital solutions-such as predictive analytics for inventory management and AI-driven procedure scheduling-will optimize resource allocation and improve patient throughput.

On the clinical front, providers should expand their service portfolios by incorporating advanced genetic testing and personalized treatment regimens. Collaborative partnerships between fertility clinics and genomic laboratories can unlock new revenue streams and enhance patient loyalty. Marketing initiatives must underscore differentiated value propositions, emphasizing success metrics, patient testimonials and transparent cost comparisons. By aligning their operational, technological and clinical strategies, industry leaders can reinforce market leadership and capitalize on emergent opportunities across diverse subsegments.

Rigorous Approach Underpinning Market Analysis

Our research methodology integrates primary and secondary data sources to deliver a holistic view of the assisted reproductive technology ecosystem. In-depth interviews with senior executives across clinical, manufacturing and logistics domains provided qualitative insights into emerging pain points and strategic priorities. Concurrently, a comprehensive review of regulatory filings, scientific publications and patent databases underpinned the assessment of technological trajectories and intellectual property trends.

Quantitative data was synthesized from validated trade databases, government statistics and proprietary shipment records to map historical adoption rates and competitive market shares. Rigorous triangulation techniques ensured data consistency and reliability across geographic regions and product categories. The research process adhered to strict ethical guidelines and confidentiality protocols, guaranteeing the integrity of respondent feedback and the robustness of analytical outputs.

Concluding Perspectives on ART Market Trajectory

As assisted reproductive technology continues its rapid evolution, stakeholders are navigating a landscape defined by innovation, regulatory complexity and shifting patient dynamics. The interplay of advanced genetic modalities, digital integration and geographic expansion is reshaping traditional care models, presenting both opportunities and challenges for providers, manufacturers and investors. Successfully steering through tariff fluctuations and supply chain constraints will require agile operational frameworks and strategic foresight.

Looking ahead, the fusion of precision medicine with patient-centric service models is poised to establish new clinical benchmarks and unlock untapped market potential. By leveraging robust segmentation insights, regional growth patterns and competitive intelligence, decision-makers can formulate targeted strategies that drive sustainable innovation and enhance reproductive health outcomes globally.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Technique
    • Gamete Intrafallopian Transfer
    • In Vitro Fertilization
      • Fresh Donor
      • Fresh Non-Donor
      • Frozen
    • Intracytoplasmic Sperm Injection
    • Intrauterine Insemination
    • Zygote Intrafallopian Transfer
  • Cycle Type
    • Fresh Donor
    • Fresh Non-Donor
    • Frozen
  • Treatment
    • Cryopreservation
    • Embryo Transfer
    • Genetic Testing
    • Oocyte Retrieval
  • End User
    • Ambulatory Surgical Centers
    • Fertility Clinics
    • Hospitals
  • Product
    • Consumables
    • Equipment
    • Media And Reagents
    • Services
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • CooperCompanies, Inc.
  • Vitrolife AB
  • FUJIFILM Irvine Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Progyny, Inc.
  • Hamilton Thorne Ltd.
  • Ovascience, Inc.
  • Cryo-Cell International, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Assisted Reproductive Technology Market, by Technique
8.1. Introduction
8.2. Gamete Intrafallopian Transfer
8.3. In Vitro Fertilization
8.3.1. Fresh Donor
8.3.2. Fresh Non-Donor
8.3.3. Frozen
8.4. Intracytoplasmic Sperm Injection
8.5. Intrauterine Insemination
8.6. Zygote Intrafallopian Transfer
9. Assisted Reproductive Technology Market, by Cycle Type
9.1. Introduction
9.2. Fresh Donor
9.3. Fresh Non-Donor
9.4. Frozen
10. Assisted Reproductive Technology Market, by Treatment
10.1. Introduction
10.2. Cryopreservation
10.3. Embryo Transfer
10.4. Genetic Testing
10.5. Oocyte Retrieval
11. Assisted Reproductive Technology Market, by End User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Fertility Clinics
11.4. Hospitals
12. Assisted Reproductive Technology Market, by Product
12.1. Introduction
12.2. Consumables
12.3. Equipment
12.4. Media And Reagents
12.5. Services
13. Americas Assisted Reproductive Technology Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Assisted Reproductive Technology Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Assisted Reproductive Technology Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck KGaA
16.3.2. Thermo Fisher Scientific Inc.
16.3.3. CooperCompanies, Inc.
16.3.4. Vitrolife AB
16.3.5. FUJIFILM Irvine Scientific, Inc.
16.3.6. Charles River Laboratories International, Inc.
16.3.7. Progyny, Inc.
16.3.8. Hamilton Thorne Ltd.
16.3.9. Ovascience, Inc.
16.3.10. Cryo-Cell International, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET MULTI-CURRENCY
FIGURE 2. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GAMETE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRACYTOPLASMIC SPERM INJECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY INTRAUTERINE INSEMINATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY ZYGOTE INTRAFALLOPIAN TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FRESH NON-DONOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FROZEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CRYOPRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EMBRYO TRANSFER, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY OOCYTE RETRIEVAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY MEDIA AND REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 48. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 49. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 50. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 51. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. CANADA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 54. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 55. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 56. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 57. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 58. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 59. MEXICO ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 63. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 65. BRAZIL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 71. ARGENTINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 82. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. UNITED KINGDOM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 85. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 86. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 87. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 88. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 90. GERMANY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 91. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 92. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. FRANCE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 100. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 102. RUSSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 104. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 105. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 106. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 107. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 108. ITALY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 109. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 111. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 112. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 113. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. SPAIN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 118. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 133. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 134. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 136. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 137. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. DENMARK ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 142. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 143. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 144. NETHERLANDS ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 145. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 146. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 147. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 148. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 149. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. QATAR ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 151. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 152. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 153. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 154. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 155. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. FINLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 160. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 161. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 162. SWEDEN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 166. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 167. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 168. NIGERIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 170. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 171. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 172. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 173. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. EGYPT ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 175. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 176. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 177. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 178. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 179. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. TURKEY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 184. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 185. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. ISRAEL ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 187. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 188. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 189. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 190. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 191. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. NORWAY ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 193. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 194. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 195. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 196. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 197. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 198. POLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 202. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 203. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 204. SWITZERLAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 212. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 213. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 214. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 215. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 216. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. CHINA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 218. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 219. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 220. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 221. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 222. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 223. INDIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 225. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 226. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 227. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 228. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. JAPAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 233. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 234. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. AUSTRALIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 239. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 240. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. SOUTH KOREA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 245. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 246. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. INDONESIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 248. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 249. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 250. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 251. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 252. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 253. THAILAND ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 257. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 258. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 259. PHILIPPINES ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 263. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 264. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. MALAYSIA ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 269. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 270. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 271. SINGAPORE ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 275. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 276. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 277. VIETNAM ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY IN VITRO FERTILIZATION, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY CYCLE TYPE, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. TAIWAN ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 284. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 285. ASSISTED REPRODUCTIVE TECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024

Companies Mentioned

The companies profiled in this Assisted Reproductive Technology market report include:
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • CooperCompanies, Inc.
  • Vitrolife AB
  • FUJIFILM Irvine Scientific, Inc.
  • Charles River Laboratories International, Inc.
  • Progyny, Inc.
  • Hamilton Thorne Ltd.
  • Ovascience, Inc.
  • Cryo-Cell International, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 34.76 Billion
Forecasted Market Value ( USD ) by 2030 $ 78.18 Billion
Compound Annual Growth Rate17.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast to 2030 - Product Image

Infertility Treatment Market by Product Type, Treatment Type, Diagnosis, End User - Global Forecast to 2030

  • Report
  • 189 Pages
  • Global
From
Assisted Reproductive Technology Market by Technology (in Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030 - Product Image

Assisted Reproductive Technology Market by Technology (in Vitro Fertilization, Artificial Insemination), Type (Instruments (Incubators), Media (Cryopreservation), Supplements, Consumables), Patient Type (Male, Female), End User - Global Forecast to 2030

  • Report
  • 321 Pages
  • Global
From
Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033 - Product Image

Assisted Reproductive Technology Global Market Opportunities and Strategies to 2033

  • Report
  • 393 Pages
  • Global
From
Assisted Reproductive Technology Market Report 2025 - Product Image

Assisted Reproductive Technology Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Assisted Reproductive Technology - Global Strategic Business Report - Product Image

Assisted Reproductive Technology - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.